Brief: Janone Says Co Encouraged By Recent FDA Communications Regarding Phase 2B Clinical Trial Design Of Lead Drug Candidate JAN101

AI Financial

28/09/2021 21:10

Sept 28 (Reuters) - Janone Inc  JAN.O :
    * JANONE ENCOURAGED BY RECENT FDA COMMUNICATIONS REGARDING
PHASE
2B CLINICAL TRIAL DESIGN OF LEAD DRUG CANDIDATE JAN101
    * JANONE - WORKING WITH PARTNERS TO INCORPORATE ALL
RECOMMENDATIONS, COMMENTS PROVIDED BY FDA INTO PHASE 2B
PROTOCOL, SUPPORTING DOCUMENTS

Source text for Eikon:  ID:nPn7KVf3Wa 
Further company coverage:  JAN.O